Regulation - Roche, Dermatologicals

Filter

Current filters:

RocheDermatologicals

Popular Filters

Genentech Ph III study of omalizumab shows promise in CIU

25-02-2013

Genentech, the US biotech subsidiary of Swiss drug major Roche (ROG: SIX), announced results from a Phase…

BiotechnologyDermatologicalsGenentechNovartisOmalizumabPharmaceuticalRegulationResearchRespiratory and PulmonaryRocheXolair

COMPANY SPOTLIGHT

Menarini

Back to top